Corcept Therapeutics, Inc. (NASDAQ:CORT)

CAPS Rating: 2 out of 5

A pharmaceutical company which is engaged in the development of drugs for the treatment of severe psychiatric and metabolic diseases.

Recs

0
Player Avatar Shankapotamus (< 20) Submitted: 2/2/2012 3:22:41 PM : Outperform Start Price: $3.28 CORT Score: +34.33

FDA catalyst play

Report this Post Reply

Featured Broker Partners


Advertisement